SDC VS STTK Stock Comparison

Performance

SDC
10/100

SDC returned -32.98% in the last 12 months. Based on SPY's performance of -7.17%, its performance is below average giving it a score of 10 of 100.

STTK
89/100

STTK returned -8.57% in the last 12 months. Based on SPY's performance of -13.98%, its performance is above average giving it a score of 88 of 100.

Sentiment

SDC
70/100

SDC had a bullish sentiment score of 69.85% across Twitter and StockTwits over the last 12 months. It had an average of 139.63 posts, 16,373.01 comments, and 17,465.68 likes per day.

STTK
71/100

STTK had a bullish sentiment score of 71.40% across Twitter and StockTwits over the last 12 months. It had an average of 1.82 posts, 0.36 comments, and 0.09 likes per day.

Technicals

SDC
82/100

SDC receives a 82 of 100 based on 14 indicators. 11 are bullish, 2 are bearish.

STTK
71/100

STTK receives a 71 of 100 based on 14 indicators. 9 are bullish, 3 are bearish.

Earnings

SDC
10/100

SDC has missed earnings 9 times in the last 20 quarters.

STTK
10/100

STTK has missed earnings 5 times in the last 20 quarters.

Profit

SDC
10/100

Out of the last 19 quarters, SDC has had 0 profitable quarters and has increased their profits year over year on 0 of them.

STTK
10/100

Out of the last 17 quarters, STTK has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

SDC
50/100

SDC has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

STTK
51/100

STTK has had a higher than average amount of volatility over the last 12 months giving it a score of 51 of 100.

All score calculations are broken down here to help you make more informed investing decisions

SmileDirectClub, Inc. Class A Common Stock Summary

Nasdaq / SDC

Healthcare

Medical Instruments & Supplies

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

Shattuck Labs, Inc. Common Stock Summary

Nasdaq / STTK

Healthcare

Biotechnology

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Power up your portfolio